The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1369

Afternoon @FloatingCity

I'm in the 99% in the positive , the only single reason I could see is the 1% that the Trial Cohort is relatively small..... but if Mechanism of Action is identified then a small cohort wouldn't matter.

I'm just being a relist ,,,, In Fact , if BP were watching, then the dip in SP and bringing new blood onto the BOD would stimulate BP to have laser focus on PAA ,,, for a position $$$$ the position gets bigger as the SP slides.... PAA would look more favourable .... the reason I don't believe a deal is waiting for us upon ODD approval is that MT would have stayed for the glory ...

Again we ' Big and Small Holders" need to wait to gather information from the BOD and the new strategy ,,,

Remember we still have 11 Patients , Talking and Swallowing and have outlived the Disease of MND by 14 to 56 months now.... and that's Valuable NZT